| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.2887034 |
| P698 | PubMed publication ID | 2887034 |
| P2093 | author name string | Cupit L | |
| Marciano F | |||
| Bohn MC | |||
| Gash DM | |||
| P433 | issue | 4817 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | striatum | Q1319792 |
| dopamine | Q170304 | ||
| P304 | page(s) | 913-916 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers | |
| P478 | volume | 237 |
| Q40980458 | A commentary on glial cell line-derived neurotrophic factor (GDNF). From a glial secreted molecule to gene therapy |
| Q70764371 | A scientific rationale for protective therapy in Parkinson's disease |
| Q40972310 | Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor |
| Q38206260 | Adrenal grafting for Parkinson's disease: a role for substance P. |
| Q48141174 | Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients. |
| Q43812070 | Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies |
| Q42090229 | Adrenal medullary transplants as a treatment for advanced Parkinson's disease |
| Q37907145 | Adrenal transplants revisited |
| Q41410412 | Animal models of age- and disease-related cognitive decline: perspectives on the models and therapeutic strategies |
| Q33939090 | Astrocyte line SVG-TH grafted in a rat model of Parkinson's disease |
| Q72033041 | Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants |
| Q41650116 | Autotransplantation for Parkinson's disease goes a step further |
| Q73947220 | Axonal sprouting following lesions of the rat substantia nigra |
| Q36932215 | Basic FGF and its Actions on Neurons: A Group Account with Special Emphasis on the Parkinsonian Brain |
| Q35209105 | CNS regeneration: clinical possibility or basic science fantasy? |
| Q38571651 | Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats |
| Q48122326 | Caudate lesions as surgical treatment in Parkinson's disease |
| Q48517875 | Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. |
| Q40909193 | Cerebral transplantation for Parkinson's disease: current progress and future prospects |
| Q48415970 | Chapter 55: neural transplantation |
| Q52110964 | Cholinergic-rich transplants alleviate cognitive deficits in lesioned rats, but exacerbate response to cholinergic drugs. |
| Q71889754 | Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test |
| Q53370289 | Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. |
| Q69255258 | Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions |
| Q64878797 | Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach |
| Q48884145 | Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra. |
| Q68684421 | Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant |
| Q68684418 | Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor |
| Q48810893 | Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern |
| Q31925371 | Effect of vagal autotransplantation on quantitative [3H]-vesamicol binding image in rats with unilateral lesions of nucleus baslis magnocellularis |
| Q42515795 | Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease |
| Q41445923 | Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue |
| Q37071593 | Evidence for plasticity of the dopaminergic system in parkinsonism |
| Q68167505 | Exogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: grafting in an animal model of Parkinson's disease |
| Q41154607 | Fetal neocortical transplants into the medial forebrain bundle attract ingrowth of catecholaminergic fibers in adult rat brain |
| Q41367101 | Fetal nigral transplantation as a therapy for Parkinson's disease |
| Q40764405 | Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. |
| Q37610792 | Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease |
| Q34026231 | Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of antonia vernadakis on neuronal-glial interactions |
| Q39429728 | Historical perspective of cell transplantation in Parkinson's disease |
| Q53562546 | Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons. |
| Q48810226 | Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion |
| Q72534294 | Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat |
| Q26829548 | Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons |
| Q41151744 | In vitro assessment of neurotrophic activity from the striatum of aging rats |
| Q41023740 | Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. |
| Q40525981 | Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy |
| Q40849460 | Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum. |
| Q71861769 | Intraspinal noradrenergic-rich implants reverse the increase ofα1 adrenoceptors densities caused by complete spinal cord transection or selective chemical denervation: a quantitative autoradiographic study |
| Q52863966 | Intrastriatal implants of mesencephalic cell suspensions in weaver mutant mice: ultrastructural relationships of dopaminergic dendrites and axons issued from the graft. |
| Q48824397 | Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats |
| Q41129499 | Long-term follow-up of adrenal medullary transplantation for Parkinson's disease |
| Q52523941 | Long-term histological follow-up of genetically modified myoblasts grafted into the brain. |
| Q41331373 | Long‐term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain |
| Q73306331 | Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts |
| Q30987686 | Magnetic resonance imaging in parkinsonism |
| Q44719793 | Mechanisms of action of adrenal medulla grafts: the possible role of peripheral and central dopamine systems |
| Q38564297 | Microparticles with neuroactive agents |
| Q71798603 | Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting |
| Q72452133 | Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease |
| Q38594489 | Neural Transplantation: A Call for Patience Rather Than Patients |
| Q48847797 | Neural grafting as a tool for the study and reversal of neurobehavioral birth defects |
| Q33541808 | Neural transplantation for Parkinson's disease |
| Q38615342 | Neural transplantation: problems and prospects--where do we go from here? |
| Q74228892 | Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: cellular mechanisms and the reversal of deficits by neural grafts |
| Q36225073 | New therapeutic approaches to Parkinson's disease including neural transplants. |
| Q42589718 | Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients |
| Q36495397 | Parkinson's disease: management |
| Q43412942 | Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior |
| Q37812285 | Past, present and future of human chromaffin cells: role in physiology and therapeutics. |
| Q35700596 | Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. |
| Q43925260 | Periwound dopaminergic sprouting is dependent on numbers of wound macrophages |
| Q43891010 | Possible mechanisms of action of adrenal transplants in Parkinson's disease. |
| Q68684402 | Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinson monkeys |
| Q36705345 | Prospects of transplantation in human neurodegenerative diseases |
| Q48762940 | Putative chromaffin cell survival and enhanced host-derived TH-Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease |
| Q48219530 | Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. |
| Q48138684 | Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla |
| Q42471107 | Release properties and functional integration of noradrenergic-rich tissue grafted to the denervated spinal cord of the adult rat. |
| Q33774931 | Repair of the damaged brain. The Alfred Meyer Memorial Lecture 1998. |
| Q43930423 | Restoration of learning ability in fornix-transected monkeys after fetal basal forebrain but not fetal hippocampal tissue transplantation |
| Q39792829 | Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors |
| Q40432525 | Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. |
| Q38036410 | Striatal adrenal medulla/sural nerve cografts in hemiparkinsonian monkeys |
| Q67900805 | Striatal implants protect the host striatum against quinolinic acid toxicity |
| Q43762264 | Survival of genetically engineered, adult-derived rat astrocytes grafted into the 6-hydroxydopamine lesioned adult rat striatum |
| Q40493894 | The History, Theory, and Present Status of Brain Transplantation |
| Q48317002 | The biology and behaviour of intracerebral adrenal transplants in animals and man. |
| Q72236568 | The effects of exogenous nerve growth factor on foetal rat adrenal cells in culture |
| Q48741286 | The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft |
| Q43512589 | The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats |
| Q45962224 | The use of fetal neocortical transplants to treat the hyperactivity resulting from cortical suction lesions in adult rats. |
| Q41661372 | The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum |
| Q48141218 | Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts |
| Q67487763 | Transplantation and functional integration of an identified respiratory interneuron in lymnaea stagnalis |
| Q37848407 | Transplantation into the central nervous system: a therapy of the future. |
| Q33631689 | Transplantation into the human brain: present status and future possibilities |
| Q48758478 | Transplantation of embryonic dopamine neurons: what we know from rats |
| Q41917888 | Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats |
| Q72844311 | Treatment of Parkinson's disease |
| Q52483193 | Treatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgery. |
| Q40679335 | Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. |
| Q47734647 | trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study |
Search more.